Quality Archives - Concept Foundation

World Preeclampsia Day – Access to quality magnesium sulfate to reduce maternal mortality

May 22, 2019

Concept Foundation, Maternal Health, Quality

magnesium sulfate, maternal health, maternal mortality, MgSO4, preeclampsia, quality, quality assured medicines

Access to quality magnesium sulfate and implementation of guidelines can help reduce maternal deaths due to preeclampsia. When a mother dies, the impact of her death reaches much further than the individual tragedy. It affects the life and health of…

WHO/UNICEF/UNFPA Joint Statement: Appropriate Storage and Management of Oxytocin – a Key Commodity for Maternal Health

March 28, 2019

Alessandra Fleurent

Concept Foundation, Maternal Health, Quality

essential medicines, maternal health, oxytocin, quality, quality assured medicines, uterotonics

No Comments

Appropriate Storage and Management of Oxytocin – a Key Commodity for Maternal Health

Access to Quality Assured generic Intramuscular DMPA continues to rise

December 18, 2018

Alessandra Fleurent

Concept Foundation, Family Planning, Quality

No Comments

Access to Quality Assured generic Intramuscular DMPA continues to rise

“The Case for Quality” report

August 31, 2018

Alessandra Fleurent

Quality

MedsWeCanTrust, QualityMeds

No Comments

Following the highly successful “Incentivising Investments in Quality Medicines” event at the World Health Assembly, USP and partners in the #MedsWeCanTrust Campaign have released a report into the learnings from the event. As a #MedsWeCanTrust partner, we are happy to share the report: The Case for Quality.

New generic IM DMPA available for procurement

July 19, 2018

Alessandra Fleurent

Family Planning, Quality, WHO PQ

family planning, generic IM DMPA, WHO

No Comments

Mylan Laboratories Limited has received a risk category 1 ranking from the WHO Expert Review Panel for its generic injectable, medroxyprogesterone acetate depot 150mg/ml.

Quality Matters: Cheap Uterotonics – Bargain or Burden?

April 29, 2016

Alessandra Fleurent

Maternal Health, Quality

carbetocin, maternal health, maternal mortality, misoprostol, oxytocin, postpartum haemorrhage, PPH, quality assured medicines, uterotonics, WHO PQ

No Comments

Fiona Theunissen, MBA and Dr Hans Vemer, CEO of Concept Foundation and former obstetrician, discuss why quality, which is by no means a given, is such an important consideration when purchasing maternal health medicines such as uterotonics.

World Preeclampsia Day – Access to quality magnesium sulfate to reduce maternal mortality

WHO/UNICEF/UNFPA Joint Statement: Appropriate Storage and Management of Oxytocin – a Key Commodity for Maternal Health

Access to Quality Assured generic Intramuscular DMPA continues to rise

“The Case for Quality” report

New generic IM DMPA available for procurement

Quality Matters: Cheap Uterotonics – Bargain or Burden?

News & Events